[Immunologic approaches tthe treatmentof leukemia. 1st results in man].
D000477:Alkylating Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D001500:BCG Vaccine; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D006801:Humans; D007116:Immunization, Passive; D007938:Leukemia / Q000276:immunology* / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000628:therapy; D007951:Leukemia, Myeloid / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000276:immunology / Q000628:therapy; D011241:Prednisone / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000477:Alkylating Agents; D000963:Antimetabolites; D001500:BCG Vaccine; D014750:Vincristine; D014747:Vinblastine; D011241:Prednisone
Approches immunologiques du traitement des leucémies. Premiers résultats chez l'homme.